Who these treatments are for GLP-1 medications are approved for adults with:Type 2 diabetesObesity (BMI of 30 kg/m or higher) A BMI of 27 kg/m or higher with at least one weight-related condition such as high blood pressure Among individuals with a BMI of 27 kg/m or more, additional benefits have been found
123 They further identified that the risk alleles, rs3761581G and rs2235312T were related to lower levels of apelin expression and nitrite, highlighting the complex interplay of genetic factors in HAPE pathogenesis
Increased abdominal obesity is linked to an elevated risk of liver disease, atherosclerosis, congestive HF (CHF), and overall cardiometabolic risk
The relentless thoughts about food, cravings, and compulsive eating often diminish dramatically
Research has shown that higher levels of carnitine in the muscles are associated with improved fat metabolism and increased endurance performance (1, 2, 3)
Cells 12 , 1207 (2023)